FDA broadens U.S. safety inquiry into AstraZeneca COVID-19 vaccine, Reuters reports

Clinical trials in the U.K., Brazil, India and South Africa resumed after the drugmaker paused them following a volunteer's “unexplained illness.”
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.